ATE525394T1 - Peptide mit verbesserten eigenschaften mit der biologischen wirkung eines vasoaktiven intestinalen peptids (vip) und ihre verwendung zur behandlung von lungenerkrankung - Google Patents

Peptide mit verbesserten eigenschaften mit der biologischen wirkung eines vasoaktiven intestinalen peptids (vip) und ihre verwendung zur behandlung von lungenerkrankung

Info

Publication number
ATE525394T1
ATE525394T1 AT08758607T AT08758607T ATE525394T1 AT E525394 T1 ATE525394 T1 AT E525394T1 AT 08758607 T AT08758607 T AT 08758607T AT 08758607 T AT08758607 T AT 08758607T AT E525394 T1 ATE525394 T1 AT E525394T1
Authority
AT
Austria
Prior art keywords
vip
treatment
vasoactive intestinal
intestinal peptide
peptides
Prior art date
Application number
AT08758607T
Other languages
English (en)
Inventor
Michael Roth-Chiarello
Original Assignee
Res Internat Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Internat Sarl filed Critical Res Internat Sarl
Application granted granted Critical
Publication of ATE525394T1 publication Critical patent/ATE525394T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
AT08758607T 2007-05-21 2008-05-19 Peptide mit verbesserten eigenschaften mit der biologischen wirkung eines vasoaktiven intestinalen peptids (vip) und ihre verwendung zur behandlung von lungenerkrankung ATE525394T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07010033 2007-05-21
PCT/EP2008/003989 WO2008141786A2 (en) 2007-05-21 2008-05-19 Peptides having the biological activity of vasoactive intestinal peptide (vip) and their use for the treatment of lung diseases

Publications (1)

Publication Number Publication Date
ATE525394T1 true ATE525394T1 (de) 2011-10-15

Family

ID=39828222

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08758607T ATE525394T1 (de) 2007-05-21 2008-05-19 Peptide mit verbesserten eigenschaften mit der biologischen wirkung eines vasoaktiven intestinalen peptids (vip) und ihre verwendung zur behandlung von lungenerkrankung

Country Status (6)

Country Link
US (1) US8329640B2 (de)
EP (1) EP2152741B1 (de)
AT (1) ATE525394T1 (de)
CA (1) CA2687602C (de)
ES (1) ES2373824T3 (de)
WO (1) WO2008141786A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
CN102131516B (zh) 2008-06-27 2016-03-16 杜克大学 包含弹性蛋白样肽的治疗剂
US9029505B2 (en) 2009-08-14 2015-05-12 Phasebio Pharmaceuticals, Inc. Modified vasoactive intestinal peptides
CA2873553C (en) 2011-06-06 2020-01-28 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
US9745384B2 (en) 2012-12-20 2017-08-29 The Brigham And Women's Hospital, Inc. Peptides useful for modulating histone demethylase function
KR20150143440A (ko) * 2013-02-15 2015-12-23 토마스 제퍼슨 유니버시티 떨어져 나가거나 순환 중인 종양세포를 생물학적 유액 내에서 탐지하는 방법
US11052132B2 (en) * 2014-05-08 2021-07-06 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating cystic fibrosis
CN114652817B (zh) 2015-02-09 2026-04-17 费斯生物制药公司 用于治疗肌肉疾病和病症的方法和组合物
EP3583933A1 (de) 2018-06-20 2019-12-25 Albert-Ludwigs-Universität Freiburg Verabreichung von aviptadil durch inhalation zur behandlung von chronischer berylliumkrankheit
CA3138891A1 (en) * 2019-05-07 2020-11-12 Advita Lifescience Gmbh Vasoactive intestinal peptide (vip) for use in the treatment of drug-induced pneumonitis
WO2022224172A1 (en) 2021-04-20 2022-10-27 Advita Lifescience Ag Use of aviptadil alone or in combination with alpha lipoic acid as a therapeutic medicament for post-viral infection syndrome
WO2023137033A1 (en) * 2022-01-12 2023-07-20 Soracco Ryan D Pharmaceutical compositions and methods
DE102024001175A1 (de) 2024-04-04 2025-10-09 ReViSan Healthcare GmbH Zubereitung zur Behandlung von entzündlichen Erkrankungen der Atemwege.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2072002A (en) * 2000-11-28 2002-06-11 Mondobiotech Sa Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension

Also Published As

Publication number Publication date
US20100256044A1 (en) 2010-10-07
CA2687602A1 (en) 2008-11-27
EP2152741A2 (de) 2010-02-17
EP2152741B1 (de) 2011-09-21
WO2008141786A3 (en) 2009-02-05
CA2687602C (en) 2014-07-15
US8329640B2 (en) 2012-12-11
WO2008141786A2 (en) 2008-11-27
ES2373824T3 (es) 2012-02-09

Similar Documents

Publication Publication Date Title
ATE525394T1 (de) Peptide mit verbesserten eigenschaften mit der biologischen wirkung eines vasoaktiven intestinalen peptids (vip) und ihre verwendung zur behandlung von lungenerkrankung
EA201000785A1 (ru) Композиции для доставки в легкие
ATE430569T1 (de) Neue arzneimittel zur behandlung von chronisch obstruktiver lungenerkrankung
UY29506A1 (es) Nuevas formas cristalinas de bromuro de tiotropio
AR066848A1 (es) Polipeptidos, dominios variables de anticuerpos y antagonistas del receptor de tipo 1 del factor de necrosis tumoral (tnfr1)
NO20083793L (no) Antistoffer mot amyloid-beta peptid
JP2017000143A5 (de)
NO20080745L (no) Nye peptider for anvendelse i behandling av fedme
ATE516285T1 (de) Dihydropyridinonderivate
JP2008514618A5 (de)
EA201100942A1 (ru) Циклические пиримидин-4-карбоксамиды в качестве антагонистов рецептора ccr2, предназначенные для лечения воспаления, астмы и хозл
BR112014007069A2 (pt) proteínas de fusão para o tratamento de distúrbios metabólicos
EA201390739A1 (ru) Способ лечения fgf21-ассоциированных расстройств
DE602005017636D1 (de) Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen
EA201100423A1 (ru) Новые бензамиды, их получение и их применение в качестве лекарственных средств
DE602008005155D1 (de) Glp-1-fc fusionsprotein-formulierung
CY1115316T1 (el) Πεπτιδια για τη θεραπευτικη αγωγη βητα-αμυλοειδωσεων
ATE364698T1 (de) Neues, physiologisch aktives peptid und dessen verwendung
AR113422A2 (es) Agentes tensioactivos reconstituidos que tienen propiedades mejoradas
ECSP22016558A (es) Proteínas de fusión terapéuticas
EP3536794A3 (de) Peptide mit spezifität für die lunge
CL2008000973A1 (es) Compuestos derivados de 1-oxo-isoquinolina; procedimiento de preparación; composición farmacéutica; y su uso en el tratamiento de enfermedades pulmonares obstructvas crónicas (epoc) y asma.
CL2009000250A1 (es) Compuestos derivados de pirazolo[3,4-b]piridina carboxamida; composicion farmaceutica que los comprende; y su uso en el tratamiento del asma, epoc y rinitis.
ATE503768T1 (de) Synthetische lungensurfactant peptide
ECSP099029A (es) Nuevos análogos del péptido intestinal vasoactivo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2152741

Country of ref document: EP